Correction - India caps prices of 52 more "essential" drugs - NPPA

MUMBAI (Reuters) - (Corrects paragraph 4 to say Merck Ltd is a unit of Merck KGaA, not Merck & Co Inc)

India has capped the prices of 52 more drugs, including painkillers and antibiotics, the pricing authority said in a notice.

The additional drugs join a list of nearly 400 essential medicines that have so far been placed under price control in India, where a majority of the people live on under $2 a day and health insurance is scarce.

The new drugs to come under price control include commonly-used antibiotics and painkillers as well as medicines used for treating cancer and skin disorders, a notice on the National Pharmaceutical Pricing Authority website said.

Companies including Lupin Ltd , Cadila Healthcare Ltd and Merck Ltd - the Indian arm of German firm Merck KGaA - are among those selling drugs mentioned in the latest notice, the authority said.

Cadila and Lupin, did not immediately respond to a request for comment. Merck's India unit was not immediately reachable.

(Reporting by Zeba Siddiqui; Editing by Anupama Dwivedi)